All In Biotech

Drug Trial Radar · NCT05470855

Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province

A Clinical Trial to Evaluate Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

Last checked: Nov 19, 2026Latest source record: Jan 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

45,400

Planned (sponsor's estimate)

Start

Jul 6, 2022

Primary completion

Nov 30, 2022

Study completion Feb 10, 2023

Sponsor

Sponsor type
Industry
First posted
Jul 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 1 year, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is Phase 4 clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the protective effect of varicella vaccine in children aged 1-12 years and the correlation between varicella antibody and protective effect,to evaluate the immunogenicity and safety of varicella vaccine in children aged 1-12 years.

Conditions

  • Varicella

Interventions

  • Live attenuated varicella vaccineBiological

    The live attenuated varicella vaccine was manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd. Live attenuated varicella-virus in 0.5 mL injection water with sucrose,sodium glutamate,sodium chloride,potassium chloride, sodium dihydrogen phosphate, potassium dihydrogen phosphate per injection.The routine of administration is intramuscular injection into deltoid region of the lateral upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence densityTime frame: 42 days after vaccination
  2. The protection rateTime frame: 42 days after vaccination

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Susong County Center for Disease Control and Prevention

    Anqing, Anhui, China

  • Laian Center for Disease Control and Prevention

    Chuzhou, Anhui, China

  • Funan County Center for Disease Control and Prevention

    Fuyang, Anhui, China

  • Huoqiu County Center for Disease Control and Prevention

    Liu‘an, Anhui, China

  • Ningguo Center for Disease Control and Prevention

    Xuancheng, Anhui, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.